Lincoln Pharmaceuticals shareholders approve all resolutions at 31st AGM

Shareholders of Lincoln Pharmaceuticals Limited have approved all ten resolutions presented at the company's 31st Annual General Meeting, which was conducted virtually on September 30, 2025. The meeting saw the adoption of the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2025, with an overwhelming 99.99% of votes cast in favor.

A key approval was the declaration of a dividend of INR 1.80 (18%) per equity share for the financial year 2024-2025, also passed with a 99.99% majority. The re-appointment of Mr. Mahendra G. Patel as managing director, Mr. Hashmukh I. Patel as whole time director, Mr. Ashish R. Patel as whole time director, and Mr. Munjal M. Patel as whole time director, all for five-year terms, were also approved, with overall favorable votes ranging from 95.50% to 96.24%.

Additionally, shareholders ratified the remuneration payable to Kiran J. Mehta & Co., cost accountants, for the financial year ending March 31, 2026, and approved the appointment of M/s. Ankit Sethi & Associates as secretarial auditors for the first term of five consecutive years, both with a 99.99% vote in favor.